TMO
52
8
EW
55
5
ED
39
8
PX
56
3
WFC
58
8
SRE
37
9
D
32
10
PPL
44
9
IPG
43
3
EFX
43
3
PRU
39
3
SNA
56
3
BF.B
35
2
XOM
33
3
TRV
34
4
VMC
41
2
SPG
45
2
VFC
56
6
MO
47
6
EA
41
3
TMO
52
8
EW
55
5
ED
39
8
PX
56
3
WFC
58
8
SRE
37
9
D
32
10
PPL
44
9
IPG
43
3
EFX
43
3
PRU
39
3
SNA
56
3
BF.B
35
2
XOM
33
3
TRV
34
4
VMC
41
2
SPG
45
2
VFC
56
6
MO
47
6
EA
41
3
Financhill
Back

MEI Pharma Vs. Revance Therapeutics Industry Stock Comparison

Sell
34

MEIP
MEI Pharma

Last Price:
$2.50
Seasonality Move:
-3.18%
Sell
13

RVNC
Revance Therapeutics

Last Price:
$3.09
Seasonality Move:
-2.77%
Sell
34
MEI Pharma (MEIP) is a Sell

Is MEI Pharma a Buy, Sell or Hold?

  • The current MEI Pharma [MEIP] share price is $2.50. The Score for MEIP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MEIP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MEIP Stock Price Chart

What is MEI Pharma's stock price today?

  • The MEI Pharma share price today is $2.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEIP is experiencing buying pressure, which is a positive indicator for future bullish movement.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.08
    The current trend is relatively stagnant and RVNC is experiencing slight buying pressure.

MEIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 31.7 Sell
Chaikin Money Flow: 114881 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.61 - 2.85) Sell
Bollinger Bands (100): (2.71 - 3.19) Sell

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 33.1 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.14 - 3.96) Sell
Bollinger Bands (100): (3.74 - 6.28) Sell

MEIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.59 Sell
20-day SMA: 2.7 Sell
50-day SMA: 2.83 Sell
200-day SMA: 3.1 Sell
8-day EMA: 2.58 Sell
20-day EMA: 2.68 Sell
50-day EMA: 2.8 Sell
200-day EMA: 3.42 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.07 Buy
20-day SMA: 3.46 Sell
50-day SMA: 4.37 Sell
200-day SMA: 4.37 Sell
8-day EMA: 3.14 Sell
20-day EMA: 3.46 Sell
50-day EMA: 4.1 Sell
200-day EMA: 5.56 Sell

MEI Pharma Earnings Growth & MEIP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.

MEI Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):